EX-99.1 2 selectquoteincmarch312022p.htm EX-99.1 Document
Exhibit 99.1
SelectQuote, Inc. Reports Third Quarter of Fiscal Year 2022 Results

Third Quarter of Fiscal Year 2022 – Consolidated Earnings Highlights

•Revenue of $275.1 million
•Net Loss of $6.4 million
•Adjusted EBITDA* of $13.0 million

•No update to Full-Year Fiscal 2022 Revenue, Net Loss and Adjusted EBITDA Guidance:
◦Revenue expected in a range of $810 million to $850 million
◦Net Loss expected in a range of $255 million to $236 million
◦Adjusted EBITDA* expected in a range of $(260) million to $(235) million

Third Quarter of Fiscal Year 2022 – Segment Highlights

Senior
•Revenue of $233.2 million
•Adjusted EBITDA* of $32.2 million
•Approved Medicare Advantage policies grew 48% Year-Over-Year

Life
•Revenue of $39.4 million
•Final expense premiums grew 15% Year-Over-Year

Auto & Home
•Revenue of $7.2 million
•Total Auto & Home premiums grew 4% Year-Over-Year

OVERLAND PARK, Kan., May 5, 2022--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the third quarter of fiscal year 2022 of $275.1 million compared to consolidated revenue for the third quarter of fiscal year 2021 of $265.3 million. Consolidated net loss for the third quarter of fiscal year 2022 was $6.4 million compared to consolidated net income for the third quarter of fiscal year 2021 of $35.2 million. Finally, consolidated Adjusted EBITDA* for the third quarter of fiscal year 2022 was $13.0 million, compared to consolidated Adjusted EBITDA* for the third quarter of fiscal year 2021 of $63.6 million.

Chief Executive Officer Tim Danker commented, “We were pleased with our third quarter results, which finished ahead of our internal expectations. During the quarter, we saw improved sales conversion rates and lower marketing cost per sale, which while early, gives us even more confidence about the steps we are taking to improve our operating and financial results. As we execute on our planned pullback in Medicare policy sales in the near term, we are focused now more than ever on delivering high-value business to our carrier partners and to improving the cash efficiency of our business. We are also thrilled with the continued momentum of the Population Health business, particularly our SelectRx pharmacy business, which ended April with over 23,000 members, a nearly 10-fold increase in less than a year.”

Raff Sadun, Chief Financial Officer, also commented, “As discussed on our second quarter call, a key aspect of our long-term strategy is to reduce the overall operating leverage of our business to deliver attractive returns in a wide range of potential market scenarios. We made major progress on that front during the quarter, identifying over $200 million in expense reduction opportunities, excluding our planned investments in the growth of our cash-efficient SelectRx business. Approximately 20% of those identified savings are fixed cost actions we already executed during the 3rd quarter. While we are not updating our 2022 guidance, so far we see similar trends in the fourth quarter and are more focused on full year 2023.”




*See reconciliation from GAAP to non-GAAP measures starting on page 11.


Segment Results

We currently report on three segments: 1) Senior, 2) Life and 3) Auto & Home. The performance measures of the segments include total revenue and Adjusted EBITDA.* Costs of revenue, marketing and advertising, and technical development operating costs and expenses that are directly attributable to a segment are reported within the applicable segment. Indirect costs of revenue, marketing and advertising, and technical development operating costs and expenses are allocated to each segment based on varying metrics such as headcount. Adjusted EBITDA* is calculated as total revenue for the applicable segment less: direct and allocated costs of revenue, marketing and advertising, technical development, and general and administrative operating costs and expenses, excluding depreciation and amortization expense; gain or loss on disposal of property, equipment, and software; share-based compensation expense; restructuring expenses; and non-recurring expenses such as severance payments and transaction costs.

Senior

Financial Results

The following table provides the financial results for the Senior segment for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
(in thousands)20222021% Change20222021% Change
Revenue$233,172 $215,600 8 %$497,459 $604,309 (18)%
Adjusted EBITDA*32,182 75,489 (57)%(149,424)218,946 (168)%
Adjusted EBITDA Margin*14 %35 %(30)%36 %

Operating Metrics

Submitted Policies

Submitted policies are counted when an individual completes an application with our licensed agent and provides authorization to the agent to submit the application to the insurance carrier partner. The applicant may have additional actions to take, such as providing additional information, before the application will be reviewed by the insurance carrier.

The following table shows the number of submitted policies for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
20222021% Change20222021% Change
Medicare Advantage242,721 160,233 51 %678,827 454,772 49 %
Medicare Supplement1,389 3,738 (63)%6,318 24,287 (74)%
Dental, Vision and Hearing40,178 38,757 4 %122,214 101,819 20 %
Prescription Drug Plan1,079 1,568 (31)%6,193 10,243 (40)%
Other4,907 6,781 (28)%11,436 12,603 (9)%
Total290,274 211,077 38 %824,988 603,724 37 %








*See reconciliation from GAAP to non-GAAP measures starting on page 11.
2

Approved Policies

Approved policies represents the number of submitted policies that were approved by our insurance carrier partners for the identified product during the indicated period. Not all approved policies will go in force.

The following table shows the number of approved policies for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
20222021% Change20222021% Change
Medicare Advantage196,377 132,950 48 %546,031 384,137 42 %
Medicare Supplement1,159 3,073 (62)%4,654 19,849 (77)%
Dental, Vision and Hearing34,486 34,517 — %101,251 84,370 20 %
Prescription Drug Plan1,095 2,109 (48)%5,315 9,556 (44)%
Other3,836 5,129 (25)%9,199 10,209 (10)%
Total236,953 177,778 33 %666,450 508,121 31 %

Lifetime Value of Commissions per Approved Policy

Lifetime value of commissions per approved policy represents commissions estimated to be collected over the estimated life of an approved policy based on multiple factors, including but not limited to, contracted commission rates, carrier mix and expected policy persistency with applied constraints. The lifetime value of commissions per approved policy is equal to the sum of the commission revenue due upon the initial sale of a policy, and when applicable, an estimate of future renewal commissions.

The following table shows the lifetime value of commissions per approved policy for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
(dollars per policy):20222021% Change20222021% Change
Medicare Advantage$933 $1,362 (31)%$935 $1,290 (28)%
Medicare Supplement949 1,345 (29)%1,275 1,263 1 %
Dental, Vision and Hearing120 129 (7)%123 140 (12)%
Prescription Drug Plan229 213 8 %235 230 2 %
Other95 60 58 %77 95 (19)%

Per Unit Economics

Per unit economics represents total Medicare Advantage and Medicare Supplement commissions, other product commissions, other revenues, and costs associated with the Senior segment, each shown per number of approved Medicare Advantage and Medicare Supplement policies over a given time period. Management assesses the business on a per-unit basis to help ensure the revenue opportunity associated with a successful policy sale is attractive relative to the marketing acquisition cost. Because not all acquired leads result in a successful policy sale, all per-policy metrics are based on approved policies, which is the measure that triggers revenue recognition.

The Medicare Advantage and Medicare Supplement commission per MA/MS policy represents the lifetime value of commissions for policies sold in the period. Other commission per MA/MS policy represents the lifetime value of commissions for other products sold in the period, including dental, vision and hearing, prescription drug plan, and other products, which management views as additional commission revenue on our agents’ core function of MA/MS policy sales. Other per MA/MS policy represents the production bonuses, lead sales revenue from InsideResponse, and updated estimates of prior period variable consideration based on actual policy renewals in the current period. Total operating expenses per MA/MS policy represents all of the operating expenses within the Senior segment. The Revenue to customer acquisition cost (“CAC”) multiple represents total revenue per MA/MS policy as a multiple of
3

total marketing acquisition cost, which represents the direct costs of acquiring leads. These costs are included in marketing and advertising expense within the total operating expenses per MA/MS policy.

The following table shows per unit economics for the periods presented. Based on the seasonality of the Senior segment and the fluctuations between quarters, we believe that the most relevant view of per unit economics is on a rolling 12-month basis. All per-MA/MS policy metrics below are based on the sum of approved MA/MS policies, as both products have similar commission profiles. These metrics are the basis on which management assesses the business:

Twelve Months Ended March 30,
(dollars per approved policy):20222021% Change
Medicare Advantage and Medicare Supplement approved policies636,195 464,653 37 %
Medicare Advantage and Medicare Supplement commission per MA/MS policy$963 $1,286 (25)%
Other commission per MA/MS policy29 38 (24)%
Other per MA/MS policy(14)166 (108)%
Total revenue per MA/MS policy978 1,490 (34)%
Total operating expenses per MA/MS policy(1,173)(947)24 %
Adjusted EBITDA per MA/MS policy*$(195)$543 (136)%
Adjusted EBITDA Margin per MA/MS policy*(20)%36 %(155)%
Revenue/CAC multiple 1.8X  3.1X

Life

Financial Results

The following table provides the financial results for the Life segment for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
(in thousands)20222021% Change20222021% Change
Revenue$39,400 $44,823 (12)%$119,612 $121,917 (2)%
Adjusted EBITDA*(1,888)1,598 (218)%2,265 16,385 (86)%
Adjusted EBITDA Margin*(5)%4 %2 %13 %

Operating Metrics

Life premium represents the total premium value for all policies that were approved by the relevant insurance carrier partner and for which the policy document was sent to the policyholder and payment information was received by the relevant insurance carrier partner during the indicated period. Because our commissions are earned based on a percentage of total premium, total premium volume for a given period is the key driver of revenue for our Life segment.










*See reconciliation from GAAP to non-GAAP measures starting on page 11.
4

The following table shows term and final expense premiums for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
(in thousands)20222021% Change20222021% Change
Term Premiums$14,933 $19,043 (22)%$45,990 $56,784 (19)%
Final Expense Premiums28,532 24,817 15 %83,718 56,269 49 %
Total$43,465 $43,860 (1)%129,708 113,053 15 %

Auto & Home

Financial Results

The following table provides the financial results for the Auto & Home segment for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
(in thousands)20222021% Change20222021% Change
Revenue$7,152 $6,973 3 %$20,755 $23,752 (13)%
Adjusted EBITDA*1,150 1,096 5 %3,957 6,863 (42)%
Adjusted EBITDA Margin*16 %16 %19 %29 %
Operating Metrics

Auto & Home premium represents the total premium value of all new policies that were approved by our insurance carrier partners during the indicated period. Because our commissions are earned based on a percentage of total premium, total premium volume for a given period is the key driver of revenue for our Auto & Home segment.

The following table shows premiums for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
(in thousands):20222021% Change20222021% Change
Premiums$12,516 $12,010 4 %$36,358 $42,165 (14)%
























*See reconciliation from GAAP to non-GAAP measures starting on page 11.
5

Earnings Conference Call

SelectQuote, Inc. will host a conference call with the investment community today, Thursday, May 5, 2022, beginning at 8:30 a.m. ET. To register for this conference call, please use this link: http://www.directeventreg.com/registration/event/1378747. After registering, a confirmation will be sent via email, including dial-in details and unique conference call codes for entry. Registration is open through the live call, but to ensure you are connected for the full call we suggest registering a day in advance or at minimum 10 minutes before the start of the call. The event will also be webcasted live via our investor relations website https://ir.selectquote.com/investor-home/default.aspx.

Non-GAAP Financial Measures

This release includes certain non-GAAP financial measures intended to supplement, not substitute for, comparable GAAP measures. To supplement our financial statements presented in accordance with GAAP and to provide investors with additional information regarding our GAAP financial results, we have presented in this release Adjusted EBITDA and Adjusted EBITDA Margin, which are non-GAAP financial measures. These non-GAAP financial measures are not based on any standardized methodology prescribed by GAAP and are not necessarily comparable to similarly titled measures presented by other companies. We define Adjusted EBITDA as income (loss) before interest expense, income tax expense (benefit), depreciation and amortization, and certain add-backs for non-cash or non-recurring expenses, including restructuring and share-based compensation expenses. The most directly comparable GAAP measure is net income (loss). We monitor and have presented in this release Adjusted EBITDA because it is a key measure used by our management and Board of Directors to understand and evaluate our operating performance, to establish budgets and to develop operational goals for managing our business. In particular, we believe that excluding the impact of these expenses in calculating Adjusted EBITDA can provide a useful measure for period-to-period comparisons of our core operating performance.

We believe that this non-GAAP financial measure helps identify underlying trends in our business that could otherwise be masked by the effect of the expenses that we exclude in the calculations of this non-GAAP financial measure. Accordingly, we believe that this financial measure provides useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance and future prospects.

Forward Looking Statement

This release contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as “may,” “should,” “could,” “predict,” “potential,” “believe,” “will likely result,” “expect,” “continue,” “will,” “anticipate,” “seek,” “estimate,” “intend,” “plan,” “projection,” “would” and “outlook,” or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements.
 
There are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the following: the ultimate duration and impact of the ongoing COVID-19 pandemic, our reliance on a limited number of insurance carrier partners and any potential termination of those relationships or failure to develop new relationships; existing and future laws and regulations affecting the health insurance market; changes in health insurance products offered by our insurance carrier partners and the health insurance market generally; insurance carriers offering products and services directly to consumers; changes to commissions paid by insurance carriers and underwriting practices; competition with brokers, exclusively online brokers and carriers who opt to sell policies directly to consumers; competition from government-run health insurance exchanges; developments in the U.S. health insurance system; our dependence on revenue from carriers in our senior segment and downturns in the senior health as well as life, automotive and home insurance industries; our ability to develop new offerings and penetrate new vertical markets; risks from third-party
6

products; failure to enroll individuals during the Medicare annual enrollment period; our ability to attract, integrate and retain qualified personnel; our dependence on lead providers and ability to compete for leads; failure to obtain and/or convert sales leads to actual sales of insurance policies; access to data from consumers and insurance carriers; accuracy of information provided from and to consumers during the insurance shopping process; cost-effective advertisement through internet search engines; ability to contact consumers and market products by telephone; global economic conditions; disruption to operations as a result of future acquisitions; significant estimates and assumptions in the preparation of our financial statements; impairment of goodwill; potential litigation and claims, including IP litigation; our existing and future indebtedness; our ability to maintain compliance with or renegotiate or obtain waivers of our debt covenants; developments with respect to LIBOR; access to additional capital; failure to protect our intellectual property and our brand; fluctuations in our financial results caused by seasonality; accuracy and timeliness of commissions reports from insurance carriers; timing of insurance carriers’ approval and payment practices; factors that impact our estimate of the constrained lifetime value of commissions per policyholder; changes in accounting rules, tax legislation and other legislation; disruptions or failures of our technological infrastructure and platform; failure to maintain relationships with third-party service providers; cybersecurity breaches or other attacks involving our systems or those of our insurance carrier partners or third-party service providers; our ability to protect consumer information and other data; and failure to market and sell Medicare plans effectively or in compliance with laws. For a further discussion of these and other risk factors that could impact our future results and performance, see the section entitled “Risk Factors” in the most recent Annual Report on Form 10-K (the “Annual Report”) filed by us with the Securities and Exchange Commission. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

About SelectQuote:

Founded in 1985, SelectQuote (NYSE: SLQT) provides solutions that help consumers protect their most valuable assets: their families, health and property. SelectQuote pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin the company’s success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads. SelectQuote has three core business lines: SelectQuote Senior, SelectQuote Life and SelectQuote Auto and Home. SelectQuote Senior, the largest and fastest-growing business, serves the needs of a demographic that sees 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. In 2021, SelectQuote expanded its business with the addition of Population Health, a healthcare services company, and SelectRx, a specialty medication management pharmacy.

Investor Relations:
Sloan Bohlen
877-678-4083
investorrelations@selectquote.com

Media:
Matt Gunter
913-286-4931
matt.gunter@selectquote.com

Source: SelectQuote, Inc.
7


SELECTQUOTE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands)

March 31, 2022June 30, 2021
ASSETS
CURRENT ASSETS:
Cash and cash equivalents$199,359 $286,454 
Accounts receivable168,735 105,298 
Commissions receivable-current77,158 89,120 
Other current assets13,246 4,486 
Total current assets458,498 485,358 
COMMISSIONS RECEIVABLE761,138 756,777 
PROPERTY AND EQUIPMENT—Net45,558 29,510 
SOFTWARE—Net15,558 12,611 
OPERATING LEASE RIGHT-OF-USE ASSETS29,018 31,414 
INTANGIBLE ASSETS—Net36,022 40,670 
GOODWILL73,732 68,019 
OTHER ASSETS15,790 1,436 
TOTAL ASSETS$1,435,314 $1,425,795 
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable$27,445 $34,079 
Accrued expenses35,593 20,676 
Accrued compensation and benefits46,229 40,909 
Operating lease liabilities—current5,181 5,289 
Current portion of long-term debt7,169 2,360 
Other current liabilities2,079 5,504 
Total current liabilities123,696 108,817 
LONG-TERM DEBT, NET—less current portion699,386 459,043 
DEFERRED INCOME TAXES76,806 139,240 
OPERATING LEASE LIABILITIES35,301 38,392 
OTHER LIABILITIES3,533 11,743 
Total liabilities938,722 757,235 
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY:
Common stock, $0.01 par value1,644 1,635 
Additional paid-in capital554,045 544,771 
Retained earnings (accumulated deficit)(68,684)121,925 
Accumulated other comprehensive income9,587 229 
Total shareholders’ equity496,592 668,560 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY$1,435,314 $1,425,795 
8

SELECTQUOTE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
(In thousands)

Three Months Ended March 31,Nine Months Ended March 31,
2022202120222021
REVENUE:
Commission$222,538 $235,216 $495,494 $660,631 
Production bonus and other52,575 30,130 132,127 85,054 
Total revenue275,113 265,346 627,621 745,685 
OPERATING COSTS AND EXPENSES:
Cost of revenue119,459 71,439 359,732 206,605 
Marketing and advertising125,082 116,690 409,005 298,696 
General and administrative21,031 19,251 64,570 44,496 
Technical development6,436 4,860 18,675 13,458 
Total operating costs and expenses272,008 212,240 851,982 563,255 
INCOME (LOSS) FROM OPERATIONS3,105 53,106 (224,361)182,430 
INTEREST EXPENSE, NET(12,179)(7,355)(31,300)(20,898)
LOSS ON EXTINGUISHMENT OF DEBT — (3,315)— (3,315)
OTHER EXPENSE, NET(23)(349)(177)(1,545)
INCOME (LOSS) BEFORE INCOME TAX EXPENSE (BENEFIT)(9,097)42,087 (255,838)156,672 
INCOME TAX EXPENSE (BENEFIT)(2,649)6,852 (65,229)31,846 
NET INCOME (LOSS)$(6,448)$35,235 $(190,609)$124,826 
NET INCOME (LOSS) PER SHARE:
Basic$(0.04)$0.21 $(1.16)$0.77 
Diluted$(0.04)$0.21 $(1.16)$0.75 
WEIGHTED-AVERAGE COMMON STOCK OUTSTANDING USED IN PER SHARE AMOUNTS:
Basic164,083 163,023 163,914 162,705 
Diluted164,083 165,731 163,914 165,495 
OTHER COMPREHENSIVE INCOME, NET OF TAX:
Gain on cash flow hedge7,589 1,810 9,358 1,669 
OTHER COMPREHENSIVE INCOME7,589 1,810 9,358 1,669 
COMPREHENSIVE INCOME (LOSS)$1,141 $37,045 $(181,251)$126,495 
9

SELECTQUOTE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)

Nine Months Ended March 31,
20222021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)$(190,609)$124,826 
Adjustments to reconcile net income (loss) to net cash and cash equivalents used in operating activities:
Depreciation and amortization17,957 11,260 
Loss on disposal of property, equipment, and software741 261 
Share-based compensation expense6,252 3,689 
Deferred income taxes(65,623)31,702 
Amortization of debt issuance costs and debt discount4,217 2,482 
Write-off of debt issuance costs— 2,570 
Fair value adjustments to contingent earnout obligations— 1,487 
Non-cash lease expense3,065 2,869 
Changes in operating assets and liabilities:
Accounts receivable(62,803)(49,224)
Commissions receivable7,601 (251,188)
Other assets(8,275)4,349 
Accounts payable and accrued expenses8,096 26,223 
Operating lease liabilities(3,868)(2,631)
Other liabilities(1,113)30,378 
Net cash used in operating activities(284,362)(60,947)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment(24,515)(6,520)
Purchases of software and capitalized software development costs(7,570)(5,807)
Acquisition of business(6,927)(23,879)
Investment in equity securities(1,000)— 
Net cash used in investing activities(40,012)(36,206)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Revolving Credit Facility50,000 — 
Payments on Revolving Credit Facility(50,000)— 
Proceeds from DDTL Facility242,000 — 
Payments on DDTL Facility(613)— 
Net proceeds from Term Loans— 228,753 
Payments on Term Loans(1,180)(84,118)
Payments on other debt(130)(189)
Proceeds from common stock options exercised and employee stock purchase plan3,179 1,778 
Payments of tax withholdings related to net share settlement of equity awards(148)(10,026)
Payments of debt issuance costs(328)(885)
Payments of costs incurred in connection with private placement— (1,771)
Payments of costs incurred in connection with initial public offering— (3,911)
Payment of contingent earnout liability— (32,300)
Payment of acquisition holdback(5,501)— 
Net cash provided by financing activities237,279 97,331 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS(87,095)178 
CASH AND CASH EQUIVALENTS—Beginning of period286,454 368,870 
CASH AND CASH EQUIVALENTS—End of period$199,359 $369,048 

10

SELECTQUOTE, INC. AND SUBSIDIARIES
Adjusted EBITDA to Net Income (Loss) Reconciliation
(Unaudited)

Three Months Ended March 31, 2022
(in thousands)SeniorLifeAuto & HomeCorp & ElimsConsolidated
Revenue$233,172 $39,400 $7,152 $(4,611)$275,113 
Operating expenses(200,990)(41,288)(6,002)(13,819)(262,099)
Other expenses, net— — — (23)(23)
Adjusted EBITDA32,182 (1,888)1,150 (18,453)12,991 
Share-based compensation expense(2,143)
Non-recurring expenses(703)
Depreciation and amortization(6,679)
Loss on disposal of property, equipment, and software, net(384)
Interest expense, net(12,179)
Income tax benefit2,649 
Net loss$(6,448)

Three Months Ended March 31, 2021
(in thousands)SeniorLifeAuto & HomeCorp & ElimsConsolidated
Revenue$215,600 $44,823 $6,973 $(2,050)$265,346 
Operating expenses(140,111)(43,225)(5,877)(12,507)(201,720)
Other expenses, net— — — (15)(15)
Adjusted EBITDA75,489 1,598 1,096 (14,572)63,611 
Share-based compensation expense(1,429)
Non-recurring expenses(4,667)
Fair value adjustments to contingent earnout obligations(334)
Depreciation and amortization(4,323)
Loss on disposal of property, equipment, and software(101)
Interest expense, net(7,355)
Loss on extinguishment of debt(3,315)
Income tax expense(6,852)
Net income$35,235 








11

SELECTQUOTE, INC. AND SUBSIDIARIES
Adjusted EBITDA to Net Income (Loss) Reconciliation
(Unaudited)

Nine Months Ended March 31, 2022
(in thousands)SeniorLifeAuto & HomeCorp & ElimsConsolidated
Revenue$497,459 $119,612 $20,755 $(10,205)$627,621 
Operating expenses(646,883)(117,347)(16,798)(43,149)(824,177)
Other expenses, net— — — (177)(177)
Adjusted EBITDA(149,424)2,265 3,957 (53,531)(196,733)
Share-based compensation expense(6,252)
Non-recurring expenses(2,857)
Depreciation and amortization(17,957)
Loss on disposal of property, equipment, and software, net(739)
Interest expense, net(31,300)
Income tax benefit65,229 
Net loss$(190,609)

Nine Months Ended March 31, 2021
(in thousands)SeniorLifeAuto & HomeCorp & ElimsConsolidated
Revenue$604,309 $121,917 $23,752 $(4,293)$745,685 
Operating expenses(385,363)(105,532)(16,889)(34,771)(542,555)
Other expenses, net— — — (58)(58)
Adjusted EBITDA218,946 16,385 6,863 (39,122)203,072 
Share-based compensation expense(3,689)
Non-recurring expenses(5,490)
Fair value adjustments to contingent earnout obligations(1,487)
Depreciation and amortization(11,260)
Loss on disposal of property, equipment, and software(261)
Interest expense, net(20,898)
Loss on extinguishment of debt(3,315)
Income tax expense(31,846)
Net income$124,826 








12

SELECTQUOTE, INC. AND SUBSIDIARIES
Net Loss to Adjusted EBITDA Reconciliation
(Unaudited)



Guidance net loss to Adjusted EBITDA reconciliation, year ending June 30, 2022:

(in thousands)Range
Net Loss$(255,000)$(236,000)
Income tax benefit(86,000)(80,000)
Interest expense, net43,000 43,000 
Depreciation and amortization22,000 22,000 
Share-based compensation expense11,000 11,000 
Non-recurring expenses5,000 5,000 
Adjusted EBITDA$(260,000)$(235,000)



13